AU Patent

AU2021409394A1 — Peptide-linked drug delivery system

Assigned to Tu Therapeutics Inc · Expires 2023-07-27 · 3y expired

What this patent protects

The present disclosure relates to a systemically administered peptide delivery platform that biodistributes to the kidney or urinary tract. The disclosure further relates to methods of treating a disease of the kidney or urinary tract in a subject in need thereof.

USPTO Abstract

The present disclosure relates to a systemically administered peptide delivery platform that biodistributes to the kidney or urinary tract. The disclosure further relates to methods of treating a disease of the kidney or urinary tract in a subject in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021409394A1
Jurisdiction
AU
Classification
—
Expires
2023-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Tu Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.